Page 18 - Read Online

Tong et al. Hepatoma Res 2019;5:36 I http://dx.doi.org/10.20517/2394-5079.2019.005 Page 13 of 13

potentially useful imaging biomarker for better survival in solitary large hepatocellular carcinoma. Liver Transpl 2013;19:283-91.
18. Chernyak V, Sirlin CB. The LI-RADS v2018 CT/MRI Manual [Internet]. The American College of Radiology; 2018 Jul. Available
from: https://www.acr.org/-/media/ACR/Files/RADS/LI-RADS/LI-RADS-2018-Core.pdf?la=en. [Last accessed on 20 Sep 2019]
19. Rosenkrantz AB, Campbell N, Wehrli N, Triolo MJ, Kim S. New OPTN/UNOS classification system for nodules in cirrhotic livers
detected with MR imaging: effect on hepatocellular carcinoma detection and transplantation allocation. Radiology 2015;274:426-33.
20. An C, Choi YA, Choi D, Paik YH, Ahn SH, et al. Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver
disease. Clin Mol Hepatol 2015;21:279.
21. Hwang SJ, Luo JC, Li CP, Chu CW, Wu JC, et al. Thrombocytosis: a paraneoplastic syndrome in patients with hepatocellular
carcinoma. World J Gastroenterol 2004;10:2472-7.
22. Carr BI, Guerra V. Thrombocytosis and hepatocellular carcinoma. Dig Dis Sci 2013;58:1790-6.
23. JK, Kim HD, Jun MJ, Yun SC, Shim JH, et al. Tumor volume doubling time as a dynamic prognostic marker for patients with
hepatocellular carcinoma. Dig Dis Sci 2017;62:2923-31.